Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis

BACKGROUND: Human epidermal growth factor receptor 2 (HER2)-low expression in breast cancer has been recently identified as a new therapeutic target. However, it is unclear if HER2-low status has an independent impact on prognosis. MATERIALS AND METHODS: A systematic literature research was carried...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinelli, C., Jacobs, F., Agostinetto, E., Nader-Marta, G., Ceppi, M., Bruzzone, M., Blondeaux, E., Schettini, F., Prat, A., Viale, G., Del Mastro, L., Lambertini, M., de Azambuja, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485402/
https://www.ncbi.nlm.nih.gov/pubmed/37413762
http://dx.doi.org/10.1016/j.esmoop.2023.101592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485402/
https://www.ncbi.nlm.nih.gov/pubmed/37413762
http://dx.doi.org/10.1016/j.esmoop.2023.101592

Ejemplares similares